Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tesetaxel: Activity of an oral taxane as first-line treatment in metastatic breast cancer
    Meeting Abstract

    Seidman, A. D.; Schwartzberg, L. S.; O'Shaughnessy, J.; D'Andrea, G.; Rubin, P.; Katz, S.; Danesi, H.; Itri, L.; Hudis, C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predicting the Oncotype DX score: An inexpensive guesstimation
    Meeting Abstract

    Pesce, C.; Stempel, M.; Eaton, A.; Patil, S.; Brogi, E.; Potz, B.; Hudis, C.; El-Tamer, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does unblinding of treatment assignment impact participant perceptions in clinical trials?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A. M.; Miller, K.; Motley, C.; Swaby, R. F.; Schneider, B. P.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Results from a phase Ib study of trastuzumab emtansine (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab
    Meeting Abstract

    Modi, S.; Elias, A. D.; LoRusso, P.; Samant, M.; Guardino, E.; Althaus, B.; Krop, I. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer (BC)
    Meeting Abstract

    Klepin, H. D.; Pitcher, B.; Ballman, K. V.; Kimmick, G. G.; Kornblith, A. B.; Cohen, H. J.; Hurria, A.; Winer, E. P.; Hudis, C.; Muss, H. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Fertility preservation options and the young breast cancer patient: A survey
    Meeting Abstract

    Junqueira, M. J.; Goldfarb, S. B.; Oppong, B. A.; Patil, S.; Eaton, A.; Olcese, C.; Morgan, J.; Kelvin, J. F.; Dickler, M. N.; Gemignani, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • MDV3100-08: A phase I open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of MDV3100 in women with incurable breast cancer
    Meeting Abstract

    Elias, A. D.; Richer, J. K.; LoRusso, P.; Peterson, A. C.; Steinberg, J. L.; Mordenti, J.; Lopez, C.; Hudis, C.; Traina, T. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer
    Meeting Abstract

    Dang, C. T.; Gianni, L.; Romieu, G.; Dirix, L.; Campone, M.; Citron, M. L.; Zamagni, C.; Krop, I. E.; Xu, N.; Smitt, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save